Literature DB >> 25631792

Evaluation of the boson chemiluminescence immunoassay as a first-line screening test in the ECDC algorithm for syphilis serodiagnosis in a population with a high prevalence of syphilis.

Xin-Hui Qiu1, Ya-Feng Zhang1, Yu-Yan Chen1, Qiao Zhang1, Fu-Yi Chen2, Long Liu3, Jin-Yi Fan1, Kun Gao1, Xiao-Zhen Zhu1, Wei-Hong Zheng1, Hui-Lin Zhang1, Li-Rong Lin1, Li-Li Liu1, Man-Li Tong1, Chang-Gong Zhang4, Jian-Jun Niu5, Tian-Ci Yang6.   

Abstract

We developed a new Boson chemiluminescence immunoassay (CIA) and evaluated its application with cross-sectional analyses. Our results indicated that the Boson CIA demonstrated strong discriminatory power in diagnosing syphilis and that it can be used as a first-line screening test for syphilis serodiagnosis using the European Centre for Disease Prevention and Control algorithm or as a confirmatory test when combined with a patient's clinical history.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25631792      PMCID: PMC4365203          DOI: 10.1128/JCM.00069-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  It is time to use treponema-specific antibody screening tests for diagnosis of syphilis.

Authors:  Michael J Loeffelholz; Matthew J Binnicker
Journal:  J Clin Microbiol       Date:  2011-11-16       Impact factor: 5.948

2.  Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management.

Authors:  Ina U Park; Joan M Chow; Gail Bolan; Mark Stanley; Jennifer Shieh; Jeffrey M Schapiro
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

3.  Serologic testing for syphilis in the United States: a cost-effectiveness analysis of two screening algorithms.

Authors:  Kwame Owusu-Edusei; Thomas A Peterman; Ronald C Ballard
Journal:  Sex Transm Dis       Date:  2011-01       Impact factor: 2.830

4.  The laboratory diagnosis of syphilis.

Authors:  Sam Ratnam
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

5.  The Architect Syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high sensitivity in primary syphilis.

Authors:  H Young; J Pryde; L Duncan; J Dave
Journal:  Sex Transm Infect       Date:  2008-09-12       Impact factor: 3.519

6.  Treponema pallidum-specific antibody expression for the diagnosis of different stages of syphilis.

Authors:  Ran Sun; Di-Hui Lai; Rong-Xin Ren; Shi Lian; Hai-Ping Zhang
Journal:  Chin Med J (Engl)       Date:  2013-01       Impact factor: 2.628

7.  Analysis of 3 algorithms for syphilis serodiagnosis and implications for clinical management.

Authors:  Man-Li Tong; Li-Rong Lin; Li-Li Liu; Hui-Lin Zhang; Song-Jie Huang; Yu-Yan Chen; Xiao-Jing Guo; Ya Xi; Long Liu; Fu-Yi Chen; Ya-Feng Zhang; Qiao Zhang; Tian-Ci Yang
Journal:  Clin Infect Dis       Date:  2014-02-18       Impact factor: 9.079

8.  Treponema-specific tests for serodiagnosis of syphilis: comparative evaluation of seven assays.

Authors:  M J Binnicker; D J Jespersen; L O Rollins
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

9.  Sexually transmitted diseases treatment guidelines, 2010.

Authors:  Kimberly A Workowski; Stuart Berman
Journal:  MMWR Recomm Rep       Date:  2010-12-17

10.  The impact of combined antiretroviral therapy on biologic false-positive rapid plasma reagin serologies in a longitudinal cohort of HIV-infected persons.

Authors:  Ikwo K Oboho; Kelly A Gebo; Richard D Moore; Khalil G Ghanem
Journal:  Clin Infect Dis       Date:  2013-07-03       Impact factor: 9.079

View more
  1 in total

Review 1.  Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects.

Authors:  Yuting Luo; Yafeng Xie; Yongjian Xiao
Journal:  Front Cell Infect Microbiol       Date:  2021-02-08       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.